Several studies described that LINC00839 was significantly elevated and could promote tumor progression in breast cancer, hepatocellular carcinoma, osteosarcoma, and neuroblastoma (26, 27, 28, 29). This evidence concerns the gene LINC00839 and hepatocellular carcinoma.